Yan Hong-Mei, Zhang Zhen-Hai, Jiang Yan-Rong, Ding Dong-Mei, Sun E, Jia Xiao-Bin
Key Laboratory of New Drug Delivery System of Chinese Materia Medica, Jiangsu Provincial Academy of Chinese Medicine; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China ; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Key Laboratory of New Drug Delivery System of Chinese Materia Medica, Jiangsu Provincial Academy of Chinese Medicine; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Pharmacogn Mag. 2014 Apr;10(Suppl 2):S311-7. doi: 10.4103/0973-1296.133286.
Tanshinone IIA (TSIIA) on solid dispersions (SDs) has thermodynamical instability of amorphous drug. Ternary solid dispersions (tSDs) can extend the stability of the amorphous form of drug. Poloxamer 188 was used as a SD carrier. Nano-CaCO3 played an important role in adsorption of biomolecules and is being developed for a host of biotechnological applications.
The aim of the present study was to investigate the dissolution behavior and accelerated stability of TSIIA on solid dispersions (SDs) by the use of ternary systems with nano-CaCO3 and poloxamer 188.
The TSIIA tSDs were prepared by a spray-drying method. First, the effect of combination of poloxamer 188 and nano-CaCO3 on TSIIA dissolution was studied. Subsequently, a set of complementary techniques (DSC, XRPD, SEM and FTIR) was used to monitor the physical changes of TSIIA in the SDs. Finally, stability test was carried out under the conditions 40°C/75% RH for 6 months.
The characterization of tSDs by differential scanning calorimetry analysis (DSC) and X-ray powder diffraction (XRPD) showed that TSIIA was present in its amorphous form. Fourier transforms infrared spectroscopy (FTIR) suggested the presence of interactions between TSIIA and carriers in tSDs. Improvement in the dissolution rate was observed for all SDs. The stability study conducted on SDs with nano-CaCO3 showed stable drug content and dissolution behavior, over the period of 6 months as compared with freshly prepared SDs.
SDs preparation with nano-CaCO3 and poloxamer 188 may be a promising approach to enhance the dissolution and stability of TSIIA.
丹参酮IIA(TSIIA)固体分散体(SDs)中的无定形药物具有热力学不稳定性。三元固体分散体(tSDs)可以延长药物无定形形式的稳定性。泊洛沙姆188用作固体分散体载体。纳米碳酸钙在生物分子吸附中起重要作用,并且正在被开发用于许多生物技术应用。
本研究的目的是通过使用含有纳米碳酸钙和泊洛沙姆188的三元体系来研究TSIIA在固体分散体(SDs)中的溶出行为和加速稳定性。
通过喷雾干燥法制备TSIIA tSDs。首先,研究泊洛沙姆188和纳米碳酸钙组合对TSIIA溶出的影响。随后,使用一组补充技术(差示扫描量热法、X射线粉末衍射、扫描电子显微镜和傅里叶变换红外光谱)来监测SDs中TSIIA的物理变化。最后,在40°C/75%相对湿度条件下进行6个月的稳定性试验。
差示扫描量热分析(DSC)和X射线粉末衍射(XRPD)对tSDs的表征表明TSIIA以无定形形式存在。傅里叶变换红外光谱(FTIR)表明tSDs中TSIIA与载体之间存在相互作用。观察到所有SDs的溶出速率均有提高。与新制备的SDs相比,对含有纳米碳酸钙的SDs进行的稳定性研究表明,在6个月的时间内药物含量和溶出行为稳定。
用纳米碳酸钙和泊洛沙姆188制备SDs可能是提高TSIIA溶出度和稳定性的一种有前景的方法。